Genome Engineer | Early R&D Scientist @SangamoTx | Postdoc @JonikasLab, @CarnegiePlants & @PrincetonMolBio | PhD @PuchtaLab, @KITKarlsruhe | Tweets are my own

Fremont, CA
Joined September 2014
🧬🚀 We’ve made substantial progress in development of our modular integrase, or MINT, platform- a gene editing method that we believe will enable large-scale genome engineering. Our updated manuscript which showcases these advances is available on bioRxiv bit.ly/41Y14ud
10
11
3
72
11,787
Friedrich Fauser retweeted
We are excited to share 71,700 new #Chlamy mutants from the CLiP2 collection pre-publication! Nearly-saturating genome coverage. Please note: new background strain, mating type, and antibiotic resistance. Read: biorxiv.org/content/10.1101/… Search and order: chlamylibrary.org/
2
32
1
133
8,732
After a mere blink in the cosmos -3 years as a preprint- our paper has found its home in @NatureComms . Thanks to all coauthors, the long supporting journey @Dinnenylab, and collaborators @JonikasLab and Michael Sussman. Oh, and by the way, I'm job hunting!!!
Preprint Alert!! We took a systems biology approach to establish #Chlamy as a simplified system to study osmotic stress pathways and identified conserved pathways across the green lineage, uncovering a new role for actin during osmotic stress acclimation, thread
9
16
2
36
10,350
One of our lead scientists, @wraithnot is presenting @FASEBorg about our exciting Modular Integrase (MINT) platform, a new approach to 🎯 integration of large 🧬 constructs into precise locations within the human genome. #genomicmedicine #MINTplatform
3
4
13
1,922
Friedrich Fauser retweeted
Our #MINTplatform does not use #CRISPR, #ZincFinger or #TALeffector to 🎯 DNA. Instead, we directly reprogram Bxb1 integrase to go where we want in the human genome. The details are in our @bioRxiv paper: bit.ly/3wwPLwy
2
1
7
1,282
We are thrilled to announce the publication of our manuscript detailing the development of our Modular Integrase (MINT) platform #MINTplatform is now live on @bioRxiv! bit.ly/3wwPLwy @f_fauser @gdavis624 @arangundy @wraithnot
9
2
21
5,195
Friedrich Fauser retweeted
Cool new preprint from Sangamo, engineering BxbI integrase to target native sites in the genome. Who needs landing pads now?
Systematic Development of Reprogrammed Modular Integrases Enables Precise Genomic Integration of Large DNA Sequences ift.tt/1aEgDKj #biorxiv_synbio
10
47
8,497
Friedrich Fauser retweeted
Today at #ASGCT2024 is the platform presentation for our next-generation Modular Integrase (MINT) technology, engineered to enable large-scale genome editing. Learn how the MINT platform utilizes Bxb1, to integrate large sequences of 🧬 into the genome. bit.ly/3QhlQyY
3
3
12
1,780
Friedrich Fauser retweeted
We are excited to announce next-generation Modular Integrase (MINT) technology, engineered to enable large-scale genome editing. The MINT platform is a versatile, protein-guided genome editing method designed to integrate large sequences of 🧬bit.ly/44GSRe4
5
9
1
30
5,387
New paper in #naturecomms unveils compact ZF Base Editor showing highly efficient engineering of human T cells by discovering a deaminase and pairing w/ a ZF nickase. Compact architecture allows packaging in a single AAV, promising in vivo therapeutic app bit.ly/3I1mvA3
8
3
46
11,120
Friedrich Fauser retweeted
After two incredible #CarnegiePlant scientists owned this Van and drove through the US, the Van is looking for a new owner. Is it again going to be a scientist ready for big adventures? #VW #VanagonGL
5
11
Friedrich Fauser retweeted
Plant Science Research Weekly -- Systematic characterization of gene function in the photosynthetic alga Chlamydomonas reinhardtii (Nature Genetics) @JinkersonLab @JonikasLab @pituvilarnadal @f_fauser (Summary by Jiawen Chen @jiaaawen) buff.ly/3a6exrS
Today at #ASGCT22, we will showcase our zinc finger platform's capabilities for high-efficiency base editing in human cells. Learn how: bit.ly/3xKCMW0 #ASGCT #GenomicMedicine #GeneTherapy #CellTherapy
Friedrich Fauser retweeted
Great energy at the #ASGCT22 conference! Quick coffee ahead of the afternoon session with Jason Fontenot, Sangamo’s CSO @JaDaFo   #GenomicMedicine #GeneTherapy #celltherapy @SangamoTx
2
12
Friedrich Fauser retweeted
Sr. Scientist David Ojala’s presentation at #ASGCT22 shared exciting progress of our proprietary approach to engineering novel AAV capsids for improved brain delivery. Proud to be part of a scientific team working so hard to improve care options for patients! @SangamoTx – at Washington, DC
2
4
2
20